Aflac Incorporated $AFL Shares Sold by Cambria Investment Management L.P.

Cambria Investment Management L.P. reduced its position in Aflac Incorporated (NYSE:AFL) by 6.2% in the 3rd quarter, Holdings Channel reports. The fund owned 114,180 shares of the financial services provider’s stock after selling 7,547 shares during the period. Aflac makes up about 0.7% of Cambria Investment Management L.P.’s investment portfolio, making the stock its 14th biggest position. Cambria Investment Management L.P.’s holdings in Aflac were worth $12,754,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. True Wealth Design LLC boosted its holdings in shares of Aflac by 188.5% during the third quarter. True Wealth Design LLC now owns 225 shares of the financial services provider’s stock worth $25,000 after purchasing an additional 147 shares during the last quarter. Darwin Wealth Management LLC purchased a new stake in shares of Aflac in the second quarter valued at $33,000. Westside Investment Management Inc. increased its stake in Aflac by 100.0% in the third quarter. Westside Investment Management Inc. now owns 324 shares of the financial services provider’s stock valued at $36,000 after purchasing an additional 162 shares during the last quarter. JCIC Asset Management Inc. acquired a new position in Aflac in the third quarter valued at $45,000. Finally, Physician Wealth Advisors Inc. lifted its position in Aflac by 110.9% during the third quarter. Physician Wealth Advisors Inc. now owns 407 shares of the financial services provider’s stock worth $45,000 after buying an additional 214 shares during the period. Hedge funds and other institutional investors own 67.44% of the company’s stock.

Insiders Place Their Bets

In related news, major shareholder Post Holdings Co. Ltd. Japan sold 17,400 shares of Aflac stock in a transaction on Friday, March 13th. The shares were sold at an average price of $109.14, for a total transaction of $1,899,036.00. Following the transaction, the insider owned 52,132,700 shares in the company, valued at approximately $5,689,762,878. The trade was a 0.03% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Charles D. Lake II sold 15,590 shares of the stock in a transaction on Wednesday, March 11th. The shares were sold at an average price of $109.93, for a total value of $1,713,808.70. Following the completion of the sale, the director owned 62,237 shares of the company’s stock, valued at approximately $6,841,713.41. This represents a 20.03% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 151,077 shares of company stock worth $16,648,784 over the last ninety days. 0.80% of the stock is owned by company insiders.

Aflac Stock Performance

Shares of NYSE:AFL opened at $109.53 on Wednesday. The business has a 50-day moving average of $111.52 and a two-hundred day moving average of $110.37. The firm has a market capitalization of $56.56 billion, a PE ratio of 15.92, a P/E/G ratio of 3.57 and a beta of 0.66. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.11 and a quick ratio of 0.11. Aflac Incorporated has a 12 month low of $96.95 and a 12 month high of $119.32.

Aflac (NYSE:AFL) last released its quarterly earnings data on Wednesday, February 4th. The financial services provider reported $1.57 earnings per share for the quarter, missing the consensus estimate of $1.69 by ($0.12). Aflac had a net margin of 21.24% and a return on equity of 14.35%. The firm had revenue of $4.28 billion during the quarter, compared to analyst estimates of $4.45 billion. During the same period in the prior year, the firm earned $1.57 earnings per share. The business’s revenue for the quarter was down 9.6% on a year-over-year basis. As a group, research analysts forecast that Aflac Incorporated will post 6.88 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the company. TD Cowen reissued a “hold” rating on shares of Aflac in a research note on Monday, December 22nd. Wall Street Zen lowered shares of Aflac from a “hold” rating to a “sell” rating in a report on Saturday, February 28th. Wells Fargo & Company raised their target price on shares of Aflac from $109.00 to $118.00 and gave the stock an “equal weight” rating in a research report on Wednesday, February 25th. Mizuho set a $107.00 target price on shares of Aflac in a report on Monday, February 9th. Finally, JPMorgan Chase & Co. increased their price target on shares of Aflac from $101.00 to $105.00 and gave the stock a “neutral” rating in a research note on Monday, January 5th. Three research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company. According to MarketBeat.com, Aflac currently has an average rating of “Hold” and a consensus target price of $111.73.

About Aflac

Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.

Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.